收藏切换
Research Progress on the Synthesis of Vaborbactam
收藏切换
Hongxia TANG1, 2, Jiawei LIANG1
Chinese Journal of Pharmaceuticals | 2026, 57(7) : 756 - 763
Less
收藏切换
Chinese Journal of Pharmaceuticals | 2026, 57(7): 756-763
• Perspectives & Review •
Research Progress on the Synthesis of Vaborbactam
Full
Hongxia TANG1, 2, Jiawei LIANG1
Affiliations
  • 1. Taizhou Hospital of Zhejiang Province, Linhai 317000
  • 2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000
Published: 2026-07-10 doi: 10.16522/j.cnki.cjph.2026.07.002
Outline
收藏切换

Vaborbactam(1) is a novel boron-containing β-lactamase inhibitor. Used in combination with meropenem, it can treat complicated urinary tract infections. This combination therapy exhibits a favorable safety profile and robust clinical efficacy alongside substantial market demand, making research into its industrial synthetic routes highly significant. This review summarizes the currently reported synthetic routes of 1. One category of routes firstly utilized chiral enzymatic resolution to obtain the enantiomer tert-butyl (R)-3-hydroxy-4-pentenoate, followed by a Matteson reaction to construct the chiral boronate intermediate. Adopting continuous flow technology for the Matteson reaction can improve efficiency and safety. Another category of routes utilizes Ellman chiral imines for asymmetric borane addition to highly selectively generate the chiral boronate intermediate, which then undergoes deprotection and cyclization to yield the target 1. These routes feature readily available starting materials, mild conditions, as well as safety and environmental friendliness.A NiH-catalyzed hydroamidation route can prepare the chiral boronate intermediate from alkenyl boronic esters in a single step without the need for chiral auxiliaries or precious metal catalysts, but it is not suitable for industrial production. This paper compares and analyzes the advantages and limitations of various synthetic routes, and proposes that the synthesis of compound 1should be optimized toward fewer reaction steps, higher yields, milder reaction conditions and greener manufacturing processes.

vaborbactam  /  urinary tract infection  /  bacterial pneumonia  /  synthesis  /  flow chemistry  /  asymmetric synthesis  /  research progress
汤红霞, 梁嘉伟. 法硼巴坦的合成研究进展. 中国医药工业杂志, 2026 , 57 (7) : 756 -763 . DOI: 10.16522/j.cnki.cjph.2026.07.002
Hongxia TANG, Jiawei LIANG. Research Progress on the Synthesis of Vaborbactam[J]. Chinese Journal of Pharmaceuticals, 2026 , 57 (7) : 756 -763 . DOI: 10.16522/j.cnki.cjph.2026.07.002
Year 2026 volume 57 Issue 7
201
63
Cite this Article
BibTeX
Article Info
doi: 10.16522/j.cnki.cjph.2026.07.002
  • Receive Date:2025-07-29
  • Online Date:2026-11-05
  • Published:2026-07-10
Article Data
Affiliations
History
  • Received:2025-07-29
Funding
Affiliations
    1. Taizhou Hospital of Zhejiang Province, Linhai 317000
    2. Taizhou Key Lab. of Pharmaceuticals Therapy and Translation Research, Linhai 317000
References
Share
https://castjournals.cast.org.cn/joweb/zgyygy/EN/10.16522/j.cnki.cjph.2026.07.002
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT